Literature DB >> 18612134

Reduced expression of cyclooxygenase-2 in primary breast cancer.

Eva-Maria Boneberg, Daniel F Legler, Hans-Jörg Senn, Gregor Fürstenberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18612134     DOI： 10.1093/jnci/djn194

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.

Authors:  Isabel Sicking; Karlien Rommens; Marco J Battista; Daniel Böhm; Susanne Gebhard; Antje Lebrecht; Cristina Cotarelo; Gerald Hoffmann; Jan G Hengstler; Marcus Schmidt
Journal:  BMC Cancer       Date:  2014-12-15       Impact factor: 4.430

Review 2.  Celecoxib in breast cancer prevention and therapy.

Authors:  Jieqing Li; Qiongyu Hao; Wei Cao; Jaydutt V Vadgama; Yong Wu
Journal:  Cancer Manag Res       Date:  2018-10-26       Impact factor: 3.989

3.  Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.

Authors:  Johanna R Reed; Ronald P Leon; Majken K Hall; Kathryn L Schwertfeger
Journal:  Breast Cancer Res       Date:  2009-04-24       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.